Joshua Doloff, assistant professor of biomedical engineering, focuses on immune engineering and regenerative medicine. His lab is interested in systems biology for understanding tissue dynamics pertaining to immunologic engagement, with applications in biomaterial/biomedical devices, controlled drug delivery systems, and synthetic cellular engineering. Specific emphasis will be applied toward engineering improved therapies in the fields of cancer, autoimmunity, and transplantation medicine (i.e. type 1 diabetes), and ophthalmology.
He was previously a Juvenile Diabetes Research Foundation (JDRF) senior postdoctoral fellow in the labs of Robert Langer and Daniel G. Anderson in Chemical Engineering and the David H. Koch Institute at MIT/Children’s Hospital Boston.
Doloff received his BSE in Bioengineering at the University of Pennsylvania in 2004; and his MA and PhD in Molecular, Cellular Biology, and Biochemistry at Boston University in 2011.
-
Researchers' work may help to predict and prevent the immune response that leads to fibrosis.